Psöriazis Hastalarında Aleksitimi Düzeyleri ve Yüzden Duygu İfadesi Tanıma Becerileri

Abstract

Bu çalışmanın amacı, psöriazis tanısı alan hastalarda aleksitimi düzeylerini ve yüzden duyguları tanıma becerilerini sağlıklı kontrollerle karşılaştırmak ve bu belirtilerin klinik önemini araştırmaktır. Dermato-loji polikliniğinde psöriazis tanısı konan 60 hastaya, yaş, eğitim ve cinsiyet olarak eşleştirilmiş 65 sağlıklı kontrole Psöriazis Alan Şiddet İndeksi (PAŞİ), psikiyatri servisinde DSM-IV eksen-1 için yapılandırılmış klinik görüşme formu, Toronto Aleksitimi Ölçeği (TAÖ), Yüzden Duygu İfadesi Tanıma Testi uygulandı. Psöriazis hastalarının TAÖ toplam ve altölçek puanlarında anlamlı bir yükseklik saptanırken, yüz ifadele-rinin büyük kısmını tanıma becerilerinin kontrol grubuna göre daha düşük bulundu. Depresyon ve anksiyete skorlarının da iki grupta benzer olmasından hareketle, hastaların muhtemelen depresyondan ve anksiyeteden korunmak amacıyla zaman içinde özellikle olumsuz duygulara yönelik bir kayıtsızlık geliştirmiş olabilecekleri değerlendirildi. Psöriazis hastalarının aleksitimi seviyeleri ile hastalık şiddeti arasında da anlamlı ilişki olduğu saptandı. Aleksitiminin psoriasis şiddetinin belirleyicilerinden biri olabileceği düşünüldü.

Keywords

• psöriazis,aleksitimi,yüzden duygu ifadesi tanıma,depresyon,anksiyete

Alexithymia Levels and Facial Emotion Recognition Skills in Psoriasis Patients

Abstract

The purpose of this study was to examine alexithymia levels and abilities to recognize facial emotions among psoriasis patients and compare with healthy controls. Sixty psoriasis patients diagnosed in dermatology clinics, and 65 age, sex and educationally matched healthy controls were assessed for this randomized controlled trial. Psoriasis Area Severity Index (PASI) was applied to patients in dermatology clinics, Structured Clinical Interview for DSM-IV Axis-1 Disorders, 20-item Toronto Alexithymia Scale (TAS-20), Facial Emotion Recognition Test (FERT) were applied to patients and controls in psychiatry clinics. Patients’ mean TAS-20 total scores were higher, while their ability to recognize negative facial emotions were lower than the control group Patients might have underestimated especially negative emotions over time, for a possible defense mechanism against depression and anxiety. Alexithymia levels were significantly related with psoriasis disease severity. Thus, alexithymia might be a predictor for severity of psoriasis.

Keywords

• psoriasis,alexithymia,facial emotion recognition,depression,anxiety

References

1. Akdemir A, Türkçapar M, Örsel S, Demirergi N, Dag I, Özbay M (2001) Reliability and validity of the Turkish version of the Hamilton Depression Rating Scale. Compr Psychiatry, 42(2):161–165.
2. Atakan N, Dogan S (2012) Psoriazis Sistemik Bir Hastalik mıdır?/Psoriasis, a Systemic Disease? Turk J Dermatol, 6(3):119-122.
3. Bagby RM, Parker JD, Taylor GJ ( 1994) The twenty-item Toronto Alexithymia Scale—I. Item selection and cross-validation of the factor structure. J Psychosom Res, 38(1): 23-32.
4. Choon SE, Lai NM, Mohammad NA, Nanu NM, Tey KE, Chew SF (2014) Clinical profile, morbidity, and outcome of adult‐onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia. Int J Dermatol, 53(6), 676-684.
5. Chung MC, Symons C, Gilliam J, Kaminski ER (2010) Stress, psychiatric co-morbidity and coping in patients with chronic idiopathic urticaria. Psychol Health, 25: 477–490.
6. Ekman P. Facial Expressions (1999) In: Handbook of Cognition and Emotion (Eds: Dalgleish T, Power M). 301–320. California: Wiley Publishers University of California.
7. Ekman P (1994) Strong evidence for universals in facial expressions: A reply to Russell’s mistaken critique. Psychol Bull, 115(2):268–287.
8. First MB, Spitzer R, Giboobn M, Williams J (1997) Structured Clinical Interview for DSM IV Clinical Version (SCID-1/CV). Washington DC and London: American Psychiatric Press.

9. Goyal S, Pisharody RR, Nath S (2017) Psychiatric morbidity in psoriasis: A case-control study. J Mar Med Soc, 19(1): 18.
10. Güleç H, Köse S, Güleç MY, Çitak S, Evren C, Borckardt J et al. (2009) Reliability and factorial validity of the Turkish version of the 20-item Toronto alexithymia scale (TAS-20). Klinik Psikofarmakol Bülteni, 19(3): 214-220.
11. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry, 23(1):56–62
12. Hamilton M (1959) The assessment of anxiety states by rating. Br. J. Med. Psychol, 32: 50–55. Jafferany M (2007) Psychodermatology: a guide to understanding common psychocutaneous disorders. Prim Care Companion J Clin Psychiatry, 9: 203–213.
13. Khosravani V, Alvani A, Sharifi Bastan F, Jamaati Ardakani R, Akbari H (2016) The alexithymia, cognitive emotion regulation, and physical symptoms in Iranian asthmatic patients. Pers Individ Dif, 101:214–219.
14. Kimball AB, Wu EQ, Guérin A, Yu AP, Tsaneva M, Gupta SR et al. (2012) Risks of developing psychiatric disorders in pediatric patients with psoriasis. J Am Acad Dermatol, 67(4): 651-657.
15. Kleyn CE, McKie S, Ross AR, Montaldi D, Gregory LJ, Elliott R et al. (2009) Diminished neural and cognitive responses to facial expressions of disgust in patients with psoriasis: a functional magnetic resonance imaging study. J Invest Dermatol, 129(11): 2613-2619.
16. Lumley MA, Neely LC, Burger AJ (2007) The assessment of alexithymia in medical settings: implications for understanding and treating health problems. J Pers Assess, 89(3): 230-246.
17. Mac Kenna RMB (1944) Psychosomatic factors in cutaneous disease. Lancet, 2: 679.
18. Meza-Concha N, Arancibia M, Salas F, Behar R, Salas G, Escobar R (2017) Towards a neurobiological understanding of alexithymia. Medwave, 17(4): e6960. Özkürkçügil A, Aydemir Ö, Yılmaz M, Esen Danacı A, Köroğlu E (1999) DSM-IV Eksen I bozuklukları için yapılandırılmış klinik görüşmenin Türkçeye uyarlanması ve güvenilirlik çalışması (Turkish adaptation and reliability study of Structured Clinical Interview for DSM-IV Axis-1 Disorders). İlaç ve Tedavi Derg, 12:233–236.
19. Pedrosa Gil F, Ridout N, Kessler H, Neuffer M, Schoechlin C, Traue HC et al. (2009) Facial emotion recognition and alexithymia in adults with somatoform disorders. Depress Anxiety, 26(1): E26-E33.
20. Pompili M, Innamorati M, Trovarelli S, Narcisi A, Bellini S, Orsini D et al. (2016) Suicide risk and psychiatric comorbidity in patients with psoriasis. J Int Med Res, 44(1): 61-66.
21. Raychaudhuri SK, Maverakis E, Raychaudhuri SP (2014) Diagnosis and classification of psoriasis. Autoimmun Rev, 13(4-5), 490-495.
22. Russo PA, Ilchef R, Cooper AJ (2004) Psychiatric morbidity in psoriasis: a review. Australas J Dermatol, 45(3): 155-161. Salminen JK, Saarijärvi S, Äärelä E, Toikka T, Kauhanen J (1999) Prevalence of alexithymia and its association with sociodemographic variables in the general population of Finland. J Psychosom Res, 46(1): 75-82.
23. Sampogna F, Puig L, Spuls P, Girolomoni G, Radtke MA, Kirby B et al. (2017) Prevalence of alexithymia in patients with psoriasis and its association with disease burden: a multicentre observational study. Br J Dermatol, 176(5): 1195-1203.
24. Sifneos PE (1973) The prevalence of alexithymic characteristics in psychosomatic patients. Psychother Psychosom, 22 (2-6): 255-262.
25. Susskind W, McGuire RJ (1959) The emotional factor in psoriasis. Scott Med J, 4:503-507.
26. Taylor GJ, Bagby RM, Parker JD (1991) The Alexithymia Construct: A Potential Paradigm for Psychosomatic Medicine. Psychosomatics, 32(2):153-164.
27. Willemsen R, Roseeuw D, Vanderlinden J (2008) Alexithymia and dermatology: the state of the art. Int J Dermatol, 47(9), 903-910.
28. Williams JBW (1988) A Structured Interview Guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry, 45(8):742.
29. Yaghmaie P, Koudelka CW, Simpson EL. Mental health comorbidity in patients with atopic dermatitis. J Allergy Clin Immunol, 2013; 131: 428–433.
30. Yazıcı M, Demir B, Tanrıverdi N, Karaağaoğlu E, Yolaç P (1998) Validity and inter-rater reliability of Hamilton Anxiety Rating Scale (Turkish). Turk Psikiyatri Derg, 9: 114–117.